Atos and Huma enter into five-year partnership to improve healthcare and research with innovative remote monitoring technologies

Paris (France), three June 2021Atos and Huma, the digital wellness innovator, have announced a 5-calendar

Paris (France), three June 2021

Atos and Huma, the digital wellness innovator, have announced a 5-calendar year strategic worldwide partnership to shift healthcare and scientific trials from medical center to residence. The partnership will target on Huma’s modular system which can electricity digital ‘hospitals at home’ up to countrywide scale, as effectively as guidance pharmaceutical and investigate industries to run complex worldwide decentralized scientific trials. The system is already applied in the US and throughout Europe for sicknesses ranging from atrial fibrillation to diabetes to Covid-19.

Atos will use its working experience in employing and scaling complex transformation initiatives to accelerate adoption of Huma’s engineering. This will consist of financial commitment by Atos well worth up to €20 million break up throughout R&D and go-to-market place means, which include devoted consulting and product sales staff. The financial commitment in R&D will rapid-monitor the integration of the Huma system with other primary scientific platforms, as effectively as build a devoted video module.

The huge force exerted by the Covid-19 pandemic on the world’s healthcare devices uncovered the weaknesses of recent types already overstretched with ageing populations and the mounting worldwide incidence of persistent situations. Innovation is wanted to boost both of those patient treatment and the total efficiency of the treatment chain. Atos and Huma’s solution implies patients are monitored outside the house of medical center and offered timely, proactive scientific intervention ahead of want, in the end optimizing the use of means, improving patient results and lowering very long-expression healthcare costs. Early stage proof has demonstrated Huma’s services, which has already been working nationally throughout Germany, England and the UAE, can almost double medical center capability.

Robert Vassoyan, Head of Wellness & Life Sciences business enterprise, Atos, explained: “We have great enjoyment about this partnership, as we are certain that Atos and Huma can travel a systemic shift from reactive to proactive types of treatment. Huma is the firm we’ve been searching for in this crucial mission that resonates with every single of us individually as we look for to boost the life of our spouse and children, buddies, neighbors and modern society. This is a partnership deserving of the mission.”

Dan Vahdat, CEO and Founder of Huma, explained: “This partnership can take us to a new league – we have already demonstrated that we can develop a services for a new ailment region in a make any difference of weeks, as we did in the course of the pandemic, and that we can go reside with above one hundred clinics in a working day. Atos will supercharge our get the job done so we can offer you products and services at scale, wherever in the entire world throughout shipping and delivery of treatment and pharma collaborations primary to more individuals living more time, fuller life.”

The partnership will reward from Huma’s course-primary program system and forty+ patents, and Atos’ considerable skilled services expertise in digital strategy, alter administration and services administration.

The 5-calendar year partnership will commence with integration, enabling worldwide go-to-market place deployments, but will also incorporate Atos’s expertise of driving digital adoption, guidance and infrastructure with Huma’s digital treatment, scientific trials and biomarkers. The organizations conservatively hope the merged services will reach €100m earnings for each calendar year in the initially four decades.

Down load the release in pdf


About Atos

Atos is a worldwide leader in digital transformation with 105,000 workforce and annual earnings of above € 11 billion. European range a single in cybersecurity, cloud and large general performance computing, the Group provides customized close-to-close methods for all industries in 71 nations. A pioneer in decarbonization products and services and merchandise, Atos is dedicated to a safe and decarbonized digital for its clientele. Atos operates underneath the manufacturers Atos and Atos|Syntel. Atos is a SE (Societas Europaea), outlined on the CAC40 Paris stock index.

The objective of Atos is to aid structure the foreseeable future of the info room. Its expertise and products and services guidance the enhancement of knowledge, training and investigate in a multicultural solution and contribute to the enhancement of scientific and technological excellence. Throughout the entire world, the Group permits its shoppers and workforce, and associates of societies at substantial to reside, get the job done and build sustainably, in a safe and sound and safe info room. www.atos.web

About Huma

Huma is a worldwide wellness engineering firm that assists individuals reside more time, fuller life. Our modular system supports digital ‘hospitals at home’ throughout unique ailment parts. In life sciences we electricity some of the world’s biggest decentralized scientific trials and studies. Our system combines artificial intelligence, digital biomarkers and true-entire world details to advance proactive, predictive treatment and investigate.

Our ‘hospitals at home’ aid treatment for patients throughout the England NHS, Wales, Germany, and the UAE — proof demonstrates they can double scientific capability, cut down readmission costs by a 3rd, and cut down costs even though providing safe and sound, large-excellent treatment. We offer you Covid-19 digital products and services, not-for-gain, to countrywide governments to aid battle towards the pandemic and have shipped above a million gadgets that enhance our ‘hospitals at home’ to aid electricity them.

Press contacts

Atos: Marion Delmas | [email protected] | +33 six 37 63 ninety one 99

Huma: Sian Jarvis, [email protected] | Ed Sykes, [email protected]